Today we are happy to welcome Frederik Groenewegen, Co-Founder and General Partner of 415 CAPITAL. He has been an investor in more than a dozen of innovative medical technology companies and currently serves as a Board Director at Cardiac Success and R3 Vascular.
In this episode you’ll learn:
- How Frederik and his family’s experience and position in MedTech led them to building 415 Capital
- How 415 Capital is leveraging a proprietary commercialization and distribution platform to win the best deals
- What Frederik has learnt from Fund I and how the team is adapting for Fund II
- How Frederik thinks about COVID as well as the current market’s impact on the MedTech space
You can also listen on your favorite podcast platforms: linktree.com/theeuropeanvc
EUVC #129 Frederik Groenewegen, 415 Capital